A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 54
- Registration Number
- NCT01815294
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-12
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 1186
- Registration Number
- NCT01809327
The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-03-12
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 29
- Registration Number
- NCT01809340
To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants
- First Posted Date
- 2013-03-12
- Last Posted Date
- 2015-03-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT01809353
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 700
- Registration Number
- NCT01804686
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇧🇪UZ Leuven Gasthuisberg, Leuven, Belgium
🇨🇳Peking University First Hospital, Beijing, China
A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy Participants
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2013-02-28
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT01800682
A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2013-04-29
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT01799603
A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2014-04-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT01798745
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 47
- Registration Number
- NCT01795703
A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2014-06-17
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 51
- Registration Number
- NCT01788436
© Copyright 2024. All Rights Reserved by MedPath